Issue: 2006 > May > short review

Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency: a report of two cases and a brief review of the literature

I.M.E. Desar, M. Keuters, J.M.M. Raemaekers, J.B.M.J. Jansen, J.H.J. van Krieken, J.W.M. van der Meer


We describe two patients with common variable
immunodeficiency (CVID ) who developed extranodal
marginal zone lymphoma (formerly described as
mucosa-associated lymphoid tissue lymphoma or MALT
lymphoma). One patient, with documented pernicious
anaemia and chronic atrophic gastritis with metaplasia,
developed a Helicobacter pylori-positive extranodal marginal zone lymphoma in the stomach. Three triple regimens of antibiotics were necessary to eliminate the H. pylori, after which the lymphoma completely regressed. Patient B had an H. pylori-negative extranodal marginal zone lymphoma of the parotid gland, which remarkably regressed after treatment with clarithromycin.
Reviewing the literature, we found eight cases of extranodal marginal zone lymphoma complicating CVID , but probably many more cases labelled as non-Hodgkin’s lymphoma are hidden in the literature.
Until more data are available on the predictive value of
noninvasive screening for pathology of the stomach, we
recommend endoscopy to assess the gastric status in
CVID patients in order to detect these malignancies at
an early stage. Elimination of H. pylori infection is the treatment of choice in Helicobacter-positive extranodal marginal zone lymphoma. The possibility of elimination failure, most probably due to frequent and prolonged exposure to antibiotics in this patient group, should be taken into account. Treatment with antibiotics in Helicobacter-negative extranodal marginal zone lymphoma must be considered.